MicroRNAs as New Characters in the Plot between Epigenetics and Prostate Cancer
Related Experiment Video
Updated: May 25, 2026

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
Alessio Paone1, Roberta Galli, Muller Fabbri
1Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University Comprehensive Cancer Center Columbus, OH, USA.
Abstract:
Prostate cancer (PCA) still represents a leading cause of death. An increasing number of studies have documented that microRNAs (miRNAs), a subgroup of non-coding RNAs with gene regulatory functions, are differentially expressed in PCA respect to the normal tissue counterpart, suggesting their involvement in prostate carcinogenesis and dissemination. Interestingly, it has been shown that miRNAs undergo the same regulatory mechanisms than any other protein coding gene, including epigenetic regulation. In turn, miRNAs can also affect the expression of oncogenes and tumor suppressor genes by targeting effectors of the epigenetic machinery, therefore indirectly affecting the epigenetic controls on these genes. Among the genes that undergo this complex regulation, there is the androgen receptor (AR), a key therapeutic target for PCA. This review will focus on the role of epigenetically regulated and epigenetically regulating miRNAs in PCA and on the fine regulation of AR expression, as mediated by this miRNA-epigenetics interaction.
Insights
MicroRNAs (miRNAs) are epigenetically regulated in prostate cancer (PCA) and influence gene expression. This review explores how miRNAs and epigenetic interactions fine-tune androgen receptor (AR) expression in PCA.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Prostate cancer (PCA) remains a significant cause of cancer-related mortality.
- MicroRNAs (miRNAs), a class of non-coding RNAs, are differentially expressed in PCA, implicating them in carcinogenesis.
- miRNAs are subject to epigenetic regulation and can, in turn, modulate epigenetic machinery, impacting oncogenes and tumor suppressors.
Purpose of the Study:
- To review the role of epigenetically regulated and epigenetically regulating miRNAs in prostate cancer.
- To elucidate the intricate interplay between miRNA-epigenetics interactions and androgen receptor (AR) regulation in PCA.
Main Methods:
- Literature review focusing on epigenetic regulation of miRNAs in PCA.
- Analysis of studies investigating miRNA targeting of epigenetic machinery.
- Examination of the impact of these interactions on AR expression.
Main Results:
- miRNAs involved in PCA pathogenesis are subject to epigenetic modifications.
- These miRNAs can influence the expression of genes controlling epigenetic processes.
- The complex interplay affects the expression of the androgen receptor (AR), a critical therapeutic target.
Conclusions:
- Epigenetic regulation of miRNAs is crucial in prostate cancer development and progression.
- miRNA-epigenetics interactions significantly influence AR signaling pathways.
- Understanding these mechanisms offers potential for novel therapeutic strategies in PCA.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Abnormal Proliferation
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...

